Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
NK cells
2:08
Streamlining cell therapy manufacturing with CliniMACS Prodigy
Saskia Rösch
• 6 Apr 2022
2:24
CAR T-cell therapy for neuroblastoma
Shigeki Yagyu
• 8 Apr 2022
2:43
Current developments in cell therapies for solid tumors
Christopher Ballas
• 27 Jan 2022
2:17
Liquid vs solid tumor strategies in cell therapy
Kanya Rajangam
• 13 Oct 2021
2:26
Advantages of allogeneic NK cell therapy
Kanya Rajangam
• 13 Oct 2021
3:05
Targetting cancer with allogeneic NK cell therapies
James Trager
• 10 Mar 2021
2:09
CAR-NKs for B cell malignancies
James Trager
• 10 Mar 2021
3:24
CYAD-101 & alloSHRINK: allogeneic CAR-T cell therapy in MSS mCRC
David Gilham
• 22 Feb 2021
2:29
CYCLE-1: next generation NKG2D-based CAR T-cells in AML/MDS
David Gilham
• 22 Feb 2021